September 1, 2023
RegMed Investors’ (RMi) pre-open: patterns exist and then they don’t
August 31, 2023
RegMed Investors’ (RMi) pre-open: gains and losses
August 30, 2023
RegMed Investors’ (RMi) pre-open: the Icarus metaphor
August 29, 2023
RegMed Investors’ (RMi) pre-open: timing
August 28, 2023
RegMed Investors’ (RMi) pre-open: musical chairs
August 25, 2023
RegMed Investors’ (RMi) pre-open: share pricing versus Jerome
August 24, 2023
RegMed Investors’ (RMi) pre-open: anticipation versus expectation
August 23, 2023
RegMed Investors’ (RMi) pre-open: the outlook for cell and gene therapy equities remains challenging
August 22, 2023
RegMed Investors’ (RMi) pre-open: risk involves uncertainty
August 21, 2023
RegMed Investors’ (RMi) pre-open: it’s time to dive into the sector’s share pricing
August 18, 2023
RegMed Investors’ (RMi) pre-open: a set-up for ending the week on a weak note
August 17, 2023
RegMed Investors’ (RMi) pre-open: risk on risk or will the cloud be lifting?
August 16, 2023
RegMed Investors’ (RMi) pre-open: futures waver casting some doubt on the session
August 15, 2023
RegMed Investors’ (RMi) pre-open: struggling momentum
August 14, 2023
RegMed Investors’ (RMi) pre-open: Investors should be holding pat, there are a few buy ops
August 11, 2023
RegMed Investors’ (RMi) pre-open: a fizzle or a sizzle?
August 10, 2023
RegMed Investors’ (RMi) pre-open: expectation of +0.2% met in consumer price index in July
August 9, 2023
RegMed Investors’ (RMi) pre-open: strolling down the lane of cratered earnings sessions
August 8, 2023
RegMed Investors’ (RMi) pre-open: earnings, earnings and more earnings
August 7, 2023
RegMed Investors’ (RMi) pre-open: after a losing week
August 4, 2023
RegMed Investors’ (RMi) pre-open: jobs data
August 3, 2023
RegMed Investors’ (RMi) pre-open: chose; Rock, paper or scissors
August 2, 2023
RegMed Investors’ (RMi) pre-open: Impact of rating actions and earnings
August 1, 2023
RegMed Investors’ (RMi) pre-open: stock futures lower as earnings’ releases begin
July 31, 2023
RegMed Investors’ (RMi) pre-open: Cash out July in its last session of month
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.